Fibrinogen Market Growth Opportunities, Business Players, and Competitive Analysis, 2023

The Global Fibrinogen Market is set to project at a CAGR of 16.7% during the forecast period. Development of novel delivery systems such as patches & sprays is stimulating the market growth. Fibrinogen plays an important role in the maintenance of homeostasis. In cases of acute blood loss, fibrinogen is the prime congealing factor to lessen the severity of blood flow.

The fibrinogen market is driven by rise in distributor channels and networks across the globe. Increase in medical advances and availability of patient pools are likely to propel the market growth in the forecast period. Development of point-of-care diagnostic testing in developed and developing countries is likely to gain a significant CAGR in the forecast period. In addition, rise in incidences for using fibrinogen testing is likely to propel the market growth during the forecast period. Subsequently, increase in cancer cases and rise of market entrants have stimulated the market growth for long. End-user segmentation for fibrinogen market includes surgical procedures and congenital fibrinogen deficiency. Product segmentation for fibrinogen market includes human fibrinogen concentrate and animal fibrinogen concentrate.


Geographical segmentation for fibrinogen market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America and Europe market is likely to gain a significant market due to change in consumer lifestyle, rising cases of cancer and high prevalence of point-of-care diagnostic tests. Asia-Pacific market is likely to gain a significant CAGR in the forecast period due to rise in non-invasive medical procedures and greater availability of patient pool.

The key players in the fibrinogen market include Avocet Medical, Baxter, CSL Bearing, LFB Group, Johnson & Johnson & Johnson, ProFibrix BV, Hualan Biological Engineering, Jiangxi Boya Bio-Pharamaceutical, Harbin Pacific Biopharmaceutical, Abbott Roche, Siemens, Sysmex, Thermo Fisher Scientific, Beckman Coulter, Shanghai XinXing Medical and Greencross.

Access Similar Category Reports @ https://industriesstudyreport.blogspot.com/

No comments:

Post a Comment

Analyzing the Impact of Corn Procurement on Revenue: A Forecasting Perspective

The Corn Category is expected to grow at a 3.1% CAGR from 2023 to 2030. The key factors driving corn demand are the rising demand for proce...